Clover Health Investments, Corp.
Price Action
Technical Summary
WEAKENINGClover Health Investments, Corp. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is moderate (RS Rating: 63), indicating performance broadly in line with the market. Earnings contraction of 102% provides fundamental context to the price action. However, price is extended 27% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $2.38 | +12.84% | ABOVE |
| 50 SMA | $2.10 | +27.32% | ABOVE |
| 100 SMA | $2.25 | +19.23% | ABOVE |
| 150 SMA | $2.43 | +10.48% | ABOVE |
| 200 SMA | $2.53 | +6.01% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is CLOV in an uptrend right now?
CLOV has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is CLOV overbought or oversold?
CLOV's RSI (14) is 67. The stock is in neutral territory, neither overbought nor oversold.
Is CLOV outperforming the market?
CLOV has a Relative Strength (RS) Rating of 63 out of 99. CLOV is performing about average compared to the market.
Where is CLOV in its 52-week range?
CLOV is trading at $2.68, which is 68% of its 52-week high ($3.92) and 47% above its 52-week low ($1.58).
How volatile is CLOV?
CLOV has a Beta of 1.22 and 52-week volatility of 67%. It's more volatile than the S&P 500 - expect bigger swings.